Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity
Kaoru Saegusa, Naozumi Ishimaru, Kumiko Yanagi, Rieko Arakaki, Kouichi Ogawa, Ichiro Saito, Nobuhiko Katunuma, Yoshio Hayashi
Kaoru Saegusa, Naozumi Ishimaru, Kumiko Yanagi, Rieko Arakaki, Kouichi Ogawa, Ichiro Saito, Nobuhiko Katunuma, Yoshio Hayashi
View: Text | PDF
Article Immunology

Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity

  • Text
  • PDF
Abstract

Research Article

Authors

Kaoru Saegusa, Naozumi Ishimaru, Kumiko Yanagi, Rieko Arakaki, Kouichi Ogawa, Ichiro Saito, Nobuhiko Katunuma, Yoshio Hayashi

×

Figure 6

Options: View larger image (or click on image) Download as PowerPoint
(a) A large proportion of class II–expressing (I-Aq–expressing) cells ob...
(a) A large proportion of class II–expressing (I-Aq–expressing) cells observed on MSG cells from SS model mice compared with those on spleen and LNCs, as determined by flow cytometry. (b) MHC class II molecule induced by IFN-γ (100 U/ml) stimulation in MSG cells from non-Tx NFS/sld control mice by flow cytometry. (c) Significant proliferative responses of purified CD4+ T cells (2 × 105) from model mice with IFN-γ–stimulated MSG cells (5 × 105 and 1 × 106, *P < 0.01, Student’s t test), but not from those with nonstimulated MSG cells. (d) Autoantigen-stimulated (JS-1–stimulated) proliferative T cell response of LNCs using MSG cells from SS model mice was significantly inhibited by the incubation with Clik60, but not the incubation with Clik148 and CA074 (*P < 0.01, Student’s t test). Data are expressed as stimulation indices ± SEM. Three experiments from each group were performed.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts